Delivery of postremission treatment, by cytogenetic risk status and treatment arm
| Risk status . | Allogeneic BMT . | Autologous BMT . | Consolidation . | Total . | ||||
|---|---|---|---|---|---|---|---|---|
| Treated/Pts . | % . | Treated/Pts . | % . | Treated/Pts . | % . | Treated/Pts . | % . | |
| Favorable | 16/19 | 84 | 17/26 | 65 | 21/22 | 95 | 54/67 | 81 |
| Intermediate | 31/47 | 66 | 22/37 | 59 | 40/44 | 91 | 93/128 | 73 |
| Unfavorable | 11/18 | 61 | 10/20 | 50 | 18/20 | 90 | 39/58 | 67 |
| Total | 58/84 | 69 | 49/83 | 59 | 79/86 | 92 | 186/253 | 74 |
| Risk status . | Allogeneic BMT . | Autologous BMT . | Consolidation . | Total . | ||||
|---|---|---|---|---|---|---|---|---|
| Treated/Pts . | % . | Treated/Pts . | % . | Treated/Pts . | % . | Treated/Pts . | % . | |
| Favorable | 16/19 | 84 | 17/26 | 65 | 21/22 | 95 | 54/67 | 81 |
| Intermediate | 31/47 | 66 | 22/37 | 59 | 40/44 | 91 | 93/128 | 73 |
| Unfavorable | 11/18 | 61 | 10/20 | 50 | 18/20 | 90 | 39/58 | 67 |
| Total | 58/84 | 69 | 49/83 | 59 | 79/86 | 92 | 186/253 | 74 |
BMT indicates bone marrow transplantation; Pts, patients.